Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
83.00    -0.80 (-0.95%)
Bid:
82.60
Ask:
83.10
Spread: 0.50 (0.605%)
Market Cap: £232.57m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Transaction in Own Shares

22 Apr 2026 08:15

RNS Number : 4682B
Essentra plc
22 April 2026
 

 

ESSENTRA PLC

Transaction in Own Shares

 

Essentra plc ("Essentra", or the "Company") announces that on 15, 16, 17 and 20 April 2026 it purchased in 161,500 ordinary shares of 25 pence each in the Company ("Ordinary Shares") from Peel Hunt LLP as part of the buyback programme announced on 29 March 2023 (the "Buyback Programme").

 

Date

Trading Venue

Volume-weighted average price paid per share (GBp)

Aggregated number of shares purchased

Lowest price paid per share (GBp):

Highest price paid per share (GBp):

 

 

 

15/04/2026

Aquis (AQXE)

-

-

-

-

BATS (BATE)

-

-

-

-

Chi-X (CHIX)

-

-

-

-

Turquoise (TRQX)

-

-

-

-

London Stock Exchange (XLON)

85.1000

11,500

85.1000

85.1000

 

 

 

16/04/2026

Aquis (AQXE)

-

-

-

-

BATS (BATE)

-

-

-

-

Chi-X (CHIX)

-

-

-

-

Turquoise (TRQX)

-

-

-

-

London Stock Exchange (XLON)

85.8000

50,000

85.8000

85.8000

 

 

17/04/2026

Aquis (AQXE)

-

-

-

-

BATS (BATE)

-

-

-

-

Chi-X (CHIX)

-

-

-

-

Turquoise (TRQX)

-

-

-

-

London Stock Exchange (XLON)

83.3700

50,000

83.3700

83.3700

 

20/04/2026

Aquis (AQXE)

-

-

-

-

BATS (BATE)

-

-

-

-

Chi-X (CHIX)

-

-

-

-

Turquoise (TRQX)

-

-

-

-

London Stock Exchange (XLON)

84.5800

50,000

84.5800

84.5800

 

Essentra intends to cancel the purchased Ordinary Shares.

 

Following the settlement of the above purchases and cancellation, Essentra will have 284,527,744 Ordinary Shares of 25 pence each in issue (excluding 3,077,057 Ordinary Shares of 25 pence each held in treasury).

 

Upon cancellation, the figure 284,527,744 will represent the total number of voting rights in Essentra and can be used by shareholders once the shares have been cancelled as the denominator for the calculations by which they can determine if they are required to notify their interest in, or change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. 

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as such Regulation has become part of domestic law by virtue of and for the purposes of the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020) and as such Regulation has been amended in such form by any regulations made under that Act), the schedule below contains detailed and aggregated information of the individual trades made by Peel Hunt LLP as part of the Buyback Programme.

 

This announcement is made in accordance with the requirements of Listing Rule 12.4.6.

 

For further enquiries, please contact:

Essentra plc

Tim George, Deputy Company Secretary

Tel: +44 (0)1908 359100

 

Schedule of Purchases - Individual Transactions

 

Number of shares purchased

Transaction price (Gbp)

Market / Sytematic Internaliser

 

Date

Time of transaction

Trade ID

11500

85.1

XLON

15/04/2026

14:24:14

 

00192360563TRLO0

 

50000

85.8

XLON

16/04/2026

08:42:17

 

00192403285TRLO0

 

50000

83.37

XLON

17/04/2026

14:00:53

 

00192503752TRLO0

 

50000

84.58

XLON

20/04/2026

13:02:22

 

00192589328TRLO0

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMZGZDNZFGVZG
Date   Source Headline
16th Jun 20267:00 amRNSDirectorate change
10th Jun 20269:47 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
29th May 20262:32 pmRNSTransaction in Own Shares
21st May 202610:55 amRNSResult of AGM
20th May 20267:00 amRNSAcquisition of Boteco Srl
20th May 20267:00 amRNS2026 AGM Trading Update
14th May 20265:15 pmRNSDirector/PDMR Shareholding
12th May 20267:03 amRNSTransaction in Own Shares
1st May 202612:17 pmRNSTotal Voting Rights
29th Apr 20268:12 amRNSTransaction in Own Shares
28th Apr 20263:25 pmRNSDirector/PDMR Shareholding
24th Apr 20263:30 pmRNSDirector/PDMR Shareholding
22nd Apr 20268:15 amRNSTransaction in Own Shares
21st Apr 20264:09 pmRNSDirector/PDMR Shareholding
17th Apr 20267:52 amRNSHolding(s) in Company
15th Apr 202610:06 amRNSDirector/PDMR Shareholding
15th Apr 20268:24 amRNSTransaction in Own Shares
15th Apr 20268:18 amRNSHolding(s) in Company
9th Apr 20268:24 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSHolding(s) in Company
1st Apr 20264:45 pmRNSDirector/PDMR Shareholding
1st Apr 20263:21 pmRNSDirector/PDMR Shareholding
1st Apr 20263:15 pmRNSTransaction in Own Shares
1st Apr 20263:08 pmRNSTotal Voting Rights
30th Mar 20262:00 pmRNSAnnual Financial Report
24th Mar 202610:05 amRNSTransaction in Own Shares
24th Mar 20268:17 amRNSHolding(s) in Company
19th Mar 20268:43 amRNSDirector/PDMR Shareholding
17th Mar 20261:41 pmRNSDirector/PDMR Shareholding
17th Mar 202610:30 amRNSDirectorate change
17th Mar 202610:28 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
17th Mar 20267:00 amRNSResults for the Full Year Ended 31 December 2025
16th Mar 20269:40 amRNSTransaction in Own Shares
16th Mar 20269:40 amRNSTransaction in Own Shares
13th Mar 202612:00 pmRNSCompany Secretary Change
9th Mar 20269:00 amRNSNotice of Full Year 2025 Results
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:58 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202612:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.